The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
There’s another universal kind-of-vaccine in development, which doesn’t tell your body what to recognize but instead tells your body how to react (primes the immune system to respond faster to respiratory infections with localized antibodies, etc)
There’s another universal kind-of-vaccine in development, which doesn’t tell your body what to recognize but instead tells your body how to react (primes the immune system to respond faster to respiratory infections with localized antibodies, etc)